Keyphrases
Progestin
100%
AKT Pathway
100%
Leiomyoma Cells
100%
Forkhead Box O1 (FOXO1)
57%
Cell Proliferation
42%
Induced Apoptosis
28%
Progesterone
28%
Phosphoinositide 3-kinase (PI3K)
14%
Uterine Leiomyoma
14%
Cell number
14%
Cell Viability
14%
Glycogen Synthase kinase-3β (GSK-3β)
14%
High Concentration
14%
Downstream Effectors
14%
Cell Apoptosis
14%
Proliferation Apoptosis
14%
Promoting Growth
14%
RU486
14%
Promote Apoptosis
14%
Phosphatidylinositol 3-kinase Inhibitor
14%
Medicine and Dentistry
Gestagen
100%
Angioleiomyoma
100%
Promegestone
100%
Programmed Cell Death
57%
Cell Proliferation
42%
Progesterone
28%
Mifepristone
14%
Phosphoinositide 3-Kinase
14%
Phosphotransferase
14%
Synthetase
14%
Cell Viability
14%
Uterine Fibroid
14%
Phosphoinositide 3-Kinase Inhibitor
14%
Glycogen Synthase Kinase
14%
Biochemistry, Genetics and Molecular Biology
Cell Proliferation
100%
FOXO1
100%
Progesterone
66%
Synthase
33%
Cell Viability
33%
Cell Count
33%
Phosphoinositide 3-Kinase
33%
Kinase
33%
Phosphotransferase
33%
Glycogen Synthase Kinase
33%
Phosphoinositide 3-Kinase Inhibitor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Leiomyoma
100%
Promegestone
100%
Progestin
100%
Progesterone
28%
Cell Viability
14%
Phosphatidylinositol 3 Kinase
14%
Phosphotransferase
14%
Uterus Myoma
14%
Synthetase
14%
Phosphatidylinositol 3 Kinase Inhibitor
14%
Mifepristone
14%
Glycogen Synthase Kinase
14%